More News – Page 149
-
NewsResearchers develop promising Lassa fever vaccine
Researchers have developed a promising new vaccine candidate that protects against Lassa fever. The vaccine effectively prevents severe cases of the disease and death in preclinical animal models and paves the way for research in people.
-
NewsGut microbiome influences location and type of immune cells
Researchers have found that different anatomical sections of the gastrointestinal tracts of mice carry different compositions of microbial communities, and the specific makeup of the microbiota can influence the type and abundance of immune cells in any particular region.
-
NewsSome guidelines for diagnosis and treatment of hepatitis E virus infection need a revamp, evaluation finds
A systematic evaluation of HEV infection guidelines revealed significant variability in their quality and recommendations. While some demonstrated strengths, others were found lacking in stakeholder involvement, rigor of development, and applicability.
-
NewsCatalogue of fungi in China reveals new taxa of macrofungi from southern Xizang
During a field trip in July 2023 in the Himalayas, 882 specimens in six counties from the border area of Xizang, China were collected, among which 15 new macrofungal species were revealed and are described in the study.
-
NewsAntibiotic usage can damage the protective mucus layer in the gut
Researchers have found that a history of repeated antibiotic use causes defects in the normally protective mucus barrier of the gut, due to antibiotic-driven alterations in the microbiota.
-
NewsTriple antibody therapy shows promise for long-lasting HIV control
A cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV, a new study shows. Some participants showed long-term control of the virus months after antibody levels declined to low or undetectable.
-
NewsCalls for more action to support vaccine uptake as new data shows two in three older people prioritise vaccine safety
A new report shows that overall trust in vaccines remains high among 50–70-year-olds but stresses more must be done to reach underserved communities and raise awareness about the risks posed by infectious respiratory illnesses.
-
NewsMachine learning could help reduce hospitalizations by nearly 30% during a pandemic, study finds
New research shows machine learning can be more effective than current methods to distribute scarce treatments to patients most vulnerable during a public health crisis.
-
NewsPowered by renewable energy, microbes turn CO2 into protein and vitamins
Researchers can harvest protein and vitamin B9 from microbes by feeding them nothing much more than hydrogen, oxygen, and CO2, a new study reveals.
-
NewsApplied Microbiology International teams up with SelectScience®
Applied Microbiology International (AMI) has announced a new partnership with laboratory science publisher SelectScience®. The two organisations will be working together on SelectScience’s upcoming CLINICAL24 campaign and beyond.
-
NewsKiller yeasts may help remedy a craft beer brewing bother
Brewing researchers have found that proteins called killer toxins, which are produced naturally by many strains of S. cerevisiae, suppress diastatic strains which can spoil craft beer through hyperattenuation, which can cause bottles to explode.
-
NewsAvian flu found in wastewater of 10 Texas cities through virome sequencing
Avian influenza A(H5N1) virus, which spread to cattle and infected 14 people this year, has been detected using virome sequencing in the wastewater of 10 Texas cities.
-
NewsStudy suggests how to curb spread of mold in future space stations
Researchers have created a predictive approach for modeling unintended microbial growth in critical spaces and applied it to life on the International Space Station. The study provides insight into how healthy environments might be maintained during future missions.
-
NewsReport recommends ‘highly ambitious enterprise’ to create world-leading UK Microbiome Biobank
A new report calls for a ’highly ambitious enterprise’ to create a microbiome biobank that will contribute significantly to the advancement of science and its application to human health.
-
NewsScientists to explore role soil microbes play in helping hemlocks survive woolly adelgid
Scientists are investigating why some stands of Eastern hemlock are able to resist a non-native, hemlock-loving invasive species known as the hemlock woolly adelgid which is wiping out the trees throughout the East Coast of the U.S.
-
NewsResearchers uncover new infection-fighting molecules through ‘molecular de-extinction’
A new study has uncovered sequences for ancient antimicrobial agents in the genomic data of extinct species, offering new hope for the development of antibacterial, antifungal, and antiviral treatments.
-
NewsNewly discovered antimicrobial could prevent or treat cholera
Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection. A study identifies the first known microcin that targets the strains of bacteria that cause cholera.
-
NewsRwanda and BGI Genomics forge stronger ties in public health collaboration
Dr. Sabin Nsanzimana, the Minister of Health of Rwanda, along with Samuel Abikunda, Commercial Counsellor from the Embassy of Rwanda in China, led a high-level delegation to BGI Genomics on September 8, 2024.
-
NewsFungal foe fended off: DNA demethylation boosts tomato resistance
A recent study discovered that applying 5-Azacytidine, a DNA methylation inhibitor, significantly reduces tomato susceptibility to gray mold, a common postharvest fungal disease.
-
NewsOne dose of smallpox vaccine moderately effective in preventing mpox infection
One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a new study.